JP Stock MarketDetailed Quotes

4582 SymBio Pharmaceuticals

Watchlist
  • 162
  • +2+1.25%
20min DelayTrading Jun 21 10:50 JST
7.42BMarket Cap-3293P/E (Static)

SymBio Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SymBio Pharmaceuticals Earnings Date

Currency: JPY

Period

Q1 FY2024 Earnings

May 7, 2024

Revenue(YoY)

597.87M

-61.30%
EPS(YoY)

-18.03

-16490.91%
Analyst Rating

No Data

SymBio Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Nov 11, 20212021/Q32.407B / ----
May 13, 20212021/Q11.420B / ----
Nov 10, 20202020/Q3972.000M / ----
May 12, 20202020/Q1551.000M / ----
Nov 8, 20192019/Q34.000M / ----
May 14, 20192019/Q11.611B / ----
DatePeriodRevenue/EstimateEarnings Call
Nov 11, 20212021/Q32.407B / ----
May 13, 20212021/Q11.420B / ----
Nov 10, 20202020/Q3972.000M / ----
May 12, 20202020/Q1551.000M / ----
Nov 8, 20192019/Q34.000M / ----
May 14, 20192019/Q11.611B / ----
--------
--------
--------
--------

Unlock Free Earnings Estimates

SymBio Pharmaceuticals Earnings Reports

  • SymBio Pharmaceuticals: Quarterly Report - 20th Quarter 1 (2024/01/01 - 2024/03/31)

    May 8 02:29 ET

  • SymBio Pharmaceuticals: Confirmation letter

    May 8 02:29 ET

  • SymBio Pharmaceuticals: Notice regarding revisions to the full-year earnings forecast for the fiscal year ending 2024/12

    May 7 04:00 ET

  • SymBio Pharmaceuticals: Summary of Financial Results for the 1st Quarter Ending 2024/12 [Japanese GAAP] (Consolidated)

    May 7 04:00 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    %Chg